Rachel K. Chikwamba

Pretoria, GT, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Translational insights into manufacturability and stability of broadly neutralizing antibodies for pediatric HIV prevention: lessons from plant-produced CAP256-VRC26.25.

Translational insights into manufacturability and stability of broadly neutralizing antibodies for pediatric HIV prevention: lessons from plant-produced CAP256-VRC26.25.

Journal: Frontiers in pediatrics

Published: March 24, 2026

From farm to bedside: Potential of medical cannabis in global health.

From farm to bedside: Potential of medical cannabis in global health.

Journal: Complementary therapies in medicine

Published: April 10, 2025

Corrigendum: Transient proteolysis reduction of Nicotiana benthamiana-produced CAP256 broadly neutralizing antibodies using CRISPR/Cas9.

Corrigendum: Transient proteolysis reduction of Nicotiana benthamiana-produced CAP256 broadly neutralizing antibodies using CRISPR/Cas9.

Journal: Frontiers in plant science

Published: January 30, 2025

Equitable drug access: small-scale manufacturing units can help.

Equitable drug access: small-scale manufacturing units can help.

Journal: Nature

Published: September 06, 2022

Transient proteolysis reduction of Nicotiana benthamiana-produced CAP256 broadly neutralizing antibodies using CRISPR/Cas9.

Transient proteolysis reduction of Nicotiana benthamiana-produced CAP256 broadly neutralizing antibodies using CRISPR/Cas9.

Journal: Frontiers in plant science

Published: May 26, 2022

Plant-based production of highly potent anti-HIV antibodies with engineered posttranslational modifications.

Plant-based production of highly potent anti-HIV antibodies with engineered posttranslational modifications.

Journal: Scientific reports

Published: July 05, 2019

The study of degradation mechanisms of glyco-engineered plant produced anti-rabies monoclonal antibodies E559 and 62-71-3.

The study of degradation mechanisms of glyco-engineered plant produced anti-rabies monoclonal antibodies E559 and 62-71-3.

Journal: PloS one

Published: July 27, 2018

Characterization of the hypersensitive response-like cell death phenomenon induced by targeting antiviral lectin griffithsin to the secretory pathway.

Characterization of the hypersensitive response-like cell death phenomenon induced by targeting antiviral lectin griffithsin to the secretory pathway.

Journal: Plant biotechnology journal

Published: July 02, 2017

The Lyssavirus glycoprotein: A key to cross-immunity.

The Lyssavirus glycoprotein: A key to cross-immunity.

Journal: Virology

Published: July 21, 2016

Evaluation of plant-produced Clostridium perfringens type D epsilon toxoid in a vaccine against enterotoxaemia in sheep.

Evaluation of plant-produced Clostridium perfringens type D epsilon toxoid in a vaccine against enterotoxaemia in sheep.

Journal: The Onderstepoort journal of veterinary research

Published: May 31, 2016

Efficient In Vitro and In Vivo Activity of Glyco-Engineered Plant-Produced Rabies Monoclonal Antibodies E559 and 62-71-3.

Efficient In Vitro and In Vivo Activity of Glyco-Engineered Plant-Produced Rabies Monoclonal Antibodies E559 and 62-71-3.

Journal: PloS one

Published: January 16, 2016

Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody.

Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody.

Journal: The Journal of infectious diseases

Published: February 11, 2014

Showing 1-12 of 17

Last Updated: 09/26/2026